Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)
CUSIP: 05153U107
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 96,296,293
- Total 13F shares
- 16,317,002
- Share change
- +517,530
- Total reported value
- $295,663,462
- Price per share
- $18.12
- Number of holders
- 43
- Value change
- +$9,714,465
- Number of buys
- 24
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 05153U107?
CUSIP 05153U107 identifies AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05153U107:
Top shareholders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
|
Company |
4.3%
|
4,112,870
|
$58,279,000 | — | 30 Jun 2022 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
3.2%
|
3,039,892
|
$43,075,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
2,312,159
|
$32,763,000 | — | 30 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
1,276,619
|
$18,090,000 | — | 30 Jun 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1%
|
1,008,814
|
$14,295,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.92%
|
886,723
|
$12,566,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
0.63%
|
603,471
|
$8,551,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
435,175
|
$6,167,000 | — | 30 Jun 2022 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.36%
|
343,215
|
$4,863,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
256,746
|
$3,638,000 | — | 30 Jun 2022 | |
| Regency Capital Management Inc.\DE |
13F
|
Company |
0.26%
|
254,622
|
$3,608,000 | — | 30 Jun 2022 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
0.22%
|
210,000
|
$2,976,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
207,294
|
$2,937,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
132,692
|
$1,881,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
123,188
|
$1,746,000 | — | 30 Jun 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.09%
|
90,539
|
$1,283,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.06%
|
61,575
|
$873,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
61,227
|
$868,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
54,526
|
$772,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
43,009
|
$610,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
42,186
|
$598,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
40,096
|
$569,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
35,343
|
$501,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
22,917
|
$325,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
20,713
|
$294,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
16,320
|
$231,000 | — | 30 Jun 2022 | |
| WATER ISLAND CAPITAL LLC |
13F
|
Company |
0.02%
|
14,541
|
$206,000 | — | 30 Jun 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
14,352
|
$203,000 | — | 30 Jun 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.01%
|
13,414
|
$190,000 | — | 30 Jun 2022 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
11,026
|
$156,238 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
9,798
|
$139,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
9,261
|
$131,000 | — | 30 Jun 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
8,577
|
$122,000 | — | 30 Jun 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
7,836
|
$111,000 | — | 30 Jun 2022 | |
| Christopher Brett Primiano |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
46,250
mixed-class rows
|
$66,863 | — | 28 Oct 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,949
|
$56,000 | — | 30 Jun 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
2,896
|
$41,000 | — | 30 Jun 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,374
|
$19,000 | — | 30 Jun 2022 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
1,280
|
$18,138 | — | 30 Jun 2022 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,300
|
$18,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
862
|
$12,000 | — | 30 Jun 2022 | |
| SUMMIT SECURITIES GROUP LLC |
13F
|
Company |
0%
|
750
|
$11,000 | — | 30 Jun 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
430
|
$6,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
103
|
$1,000 | — | 30 Jun 2022 |
Institutional Holders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) as of Q3 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.